<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordsOutput><serviceExecutionTime>390</serviceExecutionTime><Drug id="7429"><DrugName>monoclonals, Cytomed</DrugName><DrugSynonyms><Name><Value>monoclonals, Cytomed</Value></Name></DrugSynonyms><CompanyOriginator id="27307">CytoMed Inc</CompanyOriginator><CompaniesSecondary><Company id="27307">CytoMed Inc</Company></CompaniesSecondary><CrossReferences><SourceEntity id="27307" type="Company"><TargetEntity id="4296779564" type="organizationId">Cyto-Med Inc</TargetEntity></SourceEntity><SourceEntity id="188" type="ciIndication"><TargetEntity id="10061218" type="MEDDRA"></TargetEntity><TargetEntity id="D007249" type="MeSH"></TargetEntity><TargetEntity id="-308860612" type="omicsDisease"></TargetEntity><TargetEntity id="1181" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="2953" type="Action"><TargetEntity id="775" type="Mechanism">Antiinflammatory Drugs</TargetEntity><TargetEntity id="802" type="Mechanism">Mediator Release Inhibitors</TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="DX">Discontinued</PhaseHighest><IndicationsSecondary><Indication id="188">Inflammatory disease</Indication></IndicationsSecondary><ActionsSecondary><Action id="59620">Unspecified drug target</Action><Action id="2953">Anti-inflammatory</Action></ActionsSecondary><Technologies><Technology id="51">Monoclonal antibody</Technology><Technology id="761">Biological therapeutic</Technology></Technologies><LastModificationDate>2017-09-02T06:04:50.000Z</LastModificationDate><ChangeDateLast>2002-05-29T10:56:25.000Z</ChangeDateLast><AddedDate>1996-02-16T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;Cytomed was developing a series of monoclonal antibodies as a potential treatment for inflammatory conditions [&lt;ulink linkID="157665" linkType="reference"&gt;157665&lt;/ulink&gt;]. This project has now been discontinued [&lt;ulink linkID="157665" linkType="reference"&gt;157665&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="27307">CytoMed Inc</Company><Country id="US">US</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="4">Not Reported</DiscontinuedReason><Indication id="188">Inflammatory disease</Indication><Source id="215684" type="CORPORATE"/></DevelopmentStatusCurrent></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate></ReasonsForUpdate><hasSWOTs>N</hasSWOTs></Drug></drugRecordsOutput>